首页> 美国卫生研究院文献>Cancer Immunity >Possible significance of differencesin proportions of cytotoxic T cells and B-lineage cells in the tumour-infiltratinglymphocytes of typical and atypical medullary carcinomas of thebreast
【2h】

Possible significance of differencesin proportions of cytotoxic T cells and B-lineage cells in the tumour-infiltratinglymphocytes of typical and atypical medullary carcinomas of thebreast

机译:差异的可能意义肿瘤浸润中细胞毒性T细胞和B谱系细胞的比例典型和非典型髓样癌的淋巴细胞乳房

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Medullary carcinoma (MC) of the breast is a high grade carcinoma that has a relatively favourable prognosis compared to atypical medullary carcinoma (AMC) and other more common breast carcinomas. In a retrospective study in Brunei Darussalam of all available biopsy samples, we compared the nature of the tumour-infiltrating lymphocytes (TILs) in MC and AMC in relation to recorded tumour characteristics. CD4, CD8, CD20, CD25, CD45RO, and CD56 and common tumour biomarkers were detected immunohistochemically. The 11 cases of MC had no nodal metastases and survived without relapse, suggesting good tumour control. In contrast, 7 cases of nodal metastases and 1 relapse were observed in 12 AMCs. Although not statistically significant, there was a tendency for a greater proportion of AMCs to express the Her2eu oncogene. Higher proportions of CD45RO+ and CD8+ cells, and lower levels of CD20+ cells, were characteristic of TILs in MC compared to AMC. The ratio of CTL to B-lineage cells in TILs in both tumours considered together was inversely related to the expression of HER2eu and the presence of nodalmetastases. The findings suggest that CTLs, rather than antibodies,may give better tumour control in MC relative to AMC. We proposethat a comparison of the cellular, molecular and immunological characteristicsof MC and AMC, as a paired model system, in a multi-centre investigationwith a much larger number of samples will be valuable for better understandingmechanisms of tumour immunity.
机译:与非典型髓样癌(AMC)和其他更常见的乳腺癌相比,乳腺的髓样癌(MC)是预后相对较好的高级癌。在文莱达鲁萨兰国对所有可用的活检样本进行的回顾性研究中,我们比较了MC和AMC中肿瘤浸润淋巴细胞(TIL)的性质与记录的肿瘤特征。免疫组织化学检测到CD4,CD8,CD20,CD25,CD45RO和CD56和常见肿瘤生物标志物。 11例MC无淋巴结转移,并且存活下来且未复发,提示肿瘤控制良好。相比之下,在12例AMC中观察到7例淋巴结转移和1例复发。尽管在统计学上不显着,但仍有较大比例的AMC表达Her2 / neu癌基因的趋势。与AMC相比,MC中的TIL具有较高的CD45RO +和CD8 +细胞比例,以及较低的CD20 +细胞水平。一起考虑的两种肿瘤中TIL中CTL与B谱系细胞的比率与HER2 / neu的表达和结节的存在呈负相关转移。研究结果表明,CTL而非抗体,相对于AMC,MC可以更好地控制肿瘤。我们建议细胞,分子和免疫学特征的比较多中心研究中,MC和AMC作为配对模型系统大量样本将有助于更好地理解肿瘤免疫的机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号